Africa’s Pharma Logistics

Why It Matters

Limited air‑freight capacity constrains health security and economic growth across Africa, making logistics reform a strategic priority for both the pharma industry and development policymakers.

Key Takeaways

• Sub‑Saharan Africa gets only 2% of global air cargo capacity.
• Inbound pharma and outbound perishables flows rarely align.
• Fragmented regulations increase risk for temperature‑sensitive shipments.
• One‑fifth of African medicines are falsified, causing 700k deaths.
• Improved connectivity can boost vaccine access and economic growth.

Pulse Analysis

The underallocation of air‑cargo lift to Sub‑Saharan Africa reflects a structural imbalance that extends beyond logistics. While the continent accounts for roughly 15% of the world’s population, it commands a mere 2% of total air‑freight capacity. This scarcity inflates costs, elongates transit times, and forces shippers to route cargo through distant hubs such as Abu Dhabi, undermining the cold‑chain integrity essential for vaccines and biologics. By quantifying the capacity gap, Pharma.Aero’s partnership with TIACA provides a data‑driven foundation for policymakers and carriers to re‑evaluate route planning and allocate additional lift where demand is growing.

Beyond sheer capacity, the study uncovers a misalignment between inbound pharmaceutical shipments and outbound perishable goods. The two streams operate in silos, preventing efficient back‑haul utilization that could lower emissions and reduce empty‑leg costs. Addressing this disconnect requires coordinated scheduling platforms and shared visibility across industries. Moreover, fragmented regulatory frameworks across African nations add layers of compliance complexity, increasing the risk of temperature excursions and delays. Harmonising customs procedures and adopting common traceability standards would streamline cross‑border movements and bolster supply‑chain resilience.

Sustainability and safety concerns round out the challenges. Packaging that preserves cold‑chain conditions often ends up as non‑recyclable waste in remote communities, while counterfeit medicines—estimated at one in five products—claim up to 700,000 lives annually. Integrating advanced track‑and‑trace technologies, promoting recyclable packaging solutions, and fostering public‑private partnerships can mitigate these risks. Ultimately, expanding air‑freight capacity and improving regulatory cohesion not only unlocks a sizable market for cargo operators but also strengthens health outcomes and economic prospects across the African continent.